Valeant Pharmaceuticals International,
Inc. VRX today announced the completion of its
acquisition of Medicis Pharmaceutical Corporation ("Medicis") following the
approval of the transaction by stockholders of Medicis at the special meeting
held on December 7, 2012. Valeant acquired all of the common stock of Medicis
outstanding at the time of the completion of the acquisition, for $44.00 per
share in cash.
In addition, Valeant will be hosting a conference call and a live Internet
webcast along with a slide presentation on Friday, January 4, 2013 at 8:00
a.m. EST (5:00 a.m. PST) to announce 2013 financial guidance.
The dial-in number to participate on this call is (877) 295-5743, confirmation
code 80343257. International callers should dial (973) 200-3961, confirmation
code 80343257. A replay will be available approximately two hours following
the conclusion of the conference call to Friday, January 11, 2013, and can be
accessed by dialing (855) 859-2056 or (404) 537-3406, confirmation code
80343257.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in